Age-Related Survival and AML Evolution of MDS Patients Within the IPSS Subgroups
| . | No. of Patients . | Low . | Int-1 . | Int-2 . | High . |
|---|---|---|---|---|---|
| A.Median Survival (yr) | |||||
| Total no. of patients (%) | 816 | 267 (33) | 314 (38) | 176 (22) | 59 (7) |
| Median (yr) | 5.7 | 3.5 | 1.2 | 0.4 | |
| Age (yr) | |||||
| ≤60 | 205 (25) | 11.8 | 5.2 | 1.8 | 0.3 |
| >60 | 611 | 4.8 | 2.7 | 1.1 | 0.5 |
| ≤70 | 445 (54) | 9.0 | 4.4 | 1.3 | 0.4 |
| >70 | 371 | 3.9 | 2.4 | 1.2 | 0.4 |
| B.25% AML Evolution (yr) | |||||
| Total no. of patients (%) | 759 | 235 (31) | 295 (39) | 171 (22) | 58 (8) |
| Median (yr) | 9.4 | 3.3 | 1.1 | 0.2 | |
| Age (yr) | |||||
| ≤60 | 187 (25) | >9.4 (NR) | 6.9 | 0.7 | 0.2 |
| >60 | 572 | 9.4 | 2.7 | 1.3 | 0.2 |
| ≤70 | 414 (55) | >9.4 (NR) | 5.5 | 1.0 | 0.2 |
| >70 | 345 | >5.8 (NR) | 2.2 | 1.4 | 0.4 |
| . | No. of Patients . | Low . | Int-1 . | Int-2 . | High . |
|---|---|---|---|---|---|
| A.Median Survival (yr) | |||||
| Total no. of patients (%) | 816 | 267 (33) | 314 (38) | 176 (22) | 59 (7) |
| Median (yr) | 5.7 | 3.5 | 1.2 | 0.4 | |
| Age (yr) | |||||
| ≤60 | 205 (25) | 11.8 | 5.2 | 1.8 | 0.3 |
| >60 | 611 | 4.8 | 2.7 | 1.1 | 0.5 |
| ≤70 | 445 (54) | 9.0 | 4.4 | 1.3 | 0.4 |
| >70 | 371 | 3.9 | 2.4 | 1.2 | 0.4 |
| B.25% AML Evolution (yr) | |||||
| Total no. of patients (%) | 759 | 235 (31) | 295 (39) | 171 (22) | 58 (8) |
| Median (yr) | 9.4 | 3.3 | 1.1 | 0.2 | |
| Age (yr) | |||||
| ≤60 | 187 (25) | >9.4 (NR) | 6.9 | 0.7 | 0.2 |
| >60 | 572 | 9.4 | 2.7 | 1.3 | 0.2 |
| ≤70 | 414 (55) | >9.4 (NR) | 5.5 | 1.0 | 0.2 |
| >70 | 345 | >5.8 (NR) | 2.2 | 1.4 | 0.4 |
Abbreviation: NR, not reached.